Actualités Oxford Biomedica Plc - OXB | Actions London Stock Exchange

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC 03 March 2025 OXB Total Voting Rights Oxford, UK - 03 March 2025: OXB (LSE: OXB), a global quality and...

OXB to present at the Leerink Partners Global Healthcare Conference

OXB to present at the Leerink Partners Global Healthcare Conference Oxford, UK – 26 February 2025: OXB (LSE:...

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC 20 February 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name...

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II...

Oxford Biomedica PLC Standard form for notification of major holdings

Oxford Biomedica PLC 20 February 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name...

Oxford BioMedica shares fall as revenue to stay below 2022 level

Oxford BioMedica PLC on Monday said it was confident of delivering "another year of strong progress," noting strength ...

Oxford Biomedica PLC Full Year Trading Update and Notice of Results

Oxford Biomedica PLC 17 February 2025 Full Year Trading Update and Notice of Preliminary Results Full year guidance reiterated, with...

Appointment of Joint Corporate Broker and Joint Financial Adviser

Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today...

Oxford Biomedica PLC Appointment of New Joint Corporate Broker

Oxford Biomedica PLC 05 February 2025 Appointment of Joint Corporate Broker and Joint Financial Adviser Oxford, UK - 5 February...

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC 03 February 2025 OXB Total Voting Rights Oxford, UK - 03 February 2025: Oxford Biomedica Plc ( "OXB" or the...

Oxford Biomedica PLC Block Listing Application

Oxford Biomedica PLC 23 January 2025 OXB Block Listing Application Oxford, UK - 23 January 2025: OXB (LSE: OXB), a quality and...

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC 16 January 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name...

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC 16 January 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name...

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC 15 January 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name...

Oxford Biomedica PLC Block Listing Return

Oxford Biomedica PLC 02 January 2025 For Immediate Release 2 January 2025 OXFORD BIOMEDICA PLC BLOCK LISTING RETURN Name of applicant:...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Oxford Biomedica Plc (OXB)

Outils de qualité professionnelle, pour des investisseurs individuels.

OXB Actualités

Oxford Biomedica PLC Total Voting Rights

OXB to present at the Leerink Partners Global Healthcare Conference

Oxford Biomedica PLC Holding(s) in Company

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis

Oxford Biomedica PLC Standard form for notification of major holdings

Oxford BioMedica shares fall as revenue to stay below 2022 level

Oxford Biomedica PLC Full Year Trading Update and Notice of Results

Appointment of Joint Corporate Broker and Joint Financial Adviser

Oxford Biomedica PLC Appointment of New Joint Corporate Broker

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC Block Listing Application

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC Block Listing Return

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Oxford Biomedica Plc (OXB) Actualités

Oxford Biomedica Plc (OXB)

Outils de qualité professionnelle, pour des investisseurs individuels.

OXB Actualités

Oxford Biomedica PLC Total Voting Rights

OXB to present at the Leerink Partners Global Healthcare Conference

Oxford Biomedica PLC Holding(s) in Company

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis

Oxford Biomedica PLC Standard form for notification of major holdings

Oxford BioMedica shares fall as revenue to stay below 2022 level

Oxford Biomedica PLC Full Year Trading Update and Notice of Results

Appointment of Joint Corporate Broker and Joint Financial Adviser

Oxford Biomedica PLC Appointment of New Joint Corporate Broker

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC Block Listing Application

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC Block Listing Return

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités